Responses
Clinical/translational cancer immunotherapy
Original research
Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunity
Compose a Response to This Article
Other responses
No responses have been published for this article.